GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
AMICUS THERAPEUTICS (FOLD) [hlAlert]

Amicus Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of orally administered, small molecule drugs, known as pharmacological chaperones, for the
treatment of a range of human genetic diseases. The Company?s products in development are Amigal (migalastat hydrochloride) for Fabry disease, Plicera (isofagomine tartrate) for Gaucher disease and AT2220 (1-deoxynojirimycin HCl) for Pompe disease. The Company completed its Phase II clinical trials of Amigal and are conducting Phase II clinical trials of Plicera and AT2220.
.
( Total: 9 Current Stock Recommendations )
AMICUS THERAPEUTICS   (9)
Sell Hold 44% Buy 44%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
7/10/2007  
Buy
  
2/27/2009  
Buy
  
10/5/2009  
Sell
  
4/6/2010  
Buy
  
12/20/2012  
Buy
  
12/20/2012  
Hold
  
10/24/2013  
Hold
  
11/21/2013  
Hold
  
9/16/2015  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy